Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice

Diabetes

Volumn 64, Issue 2, 2015, Pages 498-507

  Pressler, Josh W ^a   Haller, April ^a   Sorrell, Joyce ^a   Wang, Fei ^a   Seeley, Randy J ^b   Tso, Patrick ^a   Sandoval, Darleen A ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; GLUCOSE; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; CARBOHYDRATE DIET; FAT INTAKE; GLUCOSE BLOOD LEVEL; MESSENGER RNA; PROTEIN INTAKE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LIPID DIET; LIPID HOMEOSTASIS; LIPID STORAGE; MACRONUTRIENT; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; VERTICAL SLEEVE GASTRECTOMY; WESTERN BLOTTING; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; C57BL MOUSE; CARBOHYDRATE DIET; FAT INTAKE; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN INTAKE;

ANIMALS; APOLIPOPROTEINS A; BLOOD GLUCOSE; BODY WEIGHT; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; GASTRECTOMY; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER;

EID: 84921913222     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0825     Document Type: Article

References (60)

1. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576
2. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.e5.
3. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247:401-407
4. Stefater MA, Wilson-Pérez HE, Chambers AP, Sandoval DA, Seeley RJ. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev 2012;33:595-622
5. Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011;141:950-958
6. Wilson-Pérez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes 2013;62:2380-2385
7. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007;30:1709-1716
8. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010;151:1588-1597
9. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011;146:143-148
10. Mokadem M, Zechner JF, Margolskee RF, Drucker DJ, Aguirre V. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab 2013;3:191-201.
11. Ye J, Hao Z, Mumphrey MB, et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol 2014;306:R352-R362
12. Stefater MA, Sandoval DA, Chambers AP, et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology 2011;141:939-949.e1-4.
13. Abu-Jaish W, Rosenthal RJ. Sleeve gastrectomy: a new surgical approach for morbid obesity. Expert Rev Gastroenterol Hepatol 2010;4:101-119
14. Nguyen NT, Varela E, Sabio A, Tran C-L, Stamos M, Wilson SE. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 2006;203:24-29
15. Zhang N, Maffei A, Cerabona T, Pahuja A, Omana J, Kaul A. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc 2013;27:1273-1280
16. Raffaelli M, Guidone C, Callari C, Iaconelli A, Bellantone R, Mingrone G. Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg 2014;259:694-699
17. Culnan DM, Cooney RN, Stanley B, Lynch CJ. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring) 2009;17:46-52
18. Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg 2009;19:1414-1423
19. Apfelbaum TF, Davidson NO, Glickman RM. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol 1987;252:G662-G666
20. Fujimoto K, Machidori H, Iwakiri R, et al. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res 1993;608:233-237
21. Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 1993;91:1830-1833
22. Tso P, Chen Q, Fujimoto K, Fukagawa K, Sakata T. Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine. Obes Res 1995;3(Suppl. 5):689S-695S
23. Gotoh K, Liu M, Benoit SC, et al. Apolipoprotein apoA-IV interacts synergistically with melanocortins to reduce food intake. Am J Physiol Regul Integr Comp Physiol 2006;290:R202-R207
24. Kohan AB, Wang F, Li X, et al. Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function. Am J Physiol Gastrointest Liver Physiol 2012;302:G628-G636
25. Ver Hague MA, Cheng D, Weinberg RB, Shelness GS. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol 2013;33:2501-2508
26. Wang F, Kohan AB, Kindel TL, et al. Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U S A 2012;109:9641-9646
27. Chambers AP, Kirchner H, Wilson-Perez HE, et al. The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology 2013;144:50-52.e5.
28. Lamont BJ, Li Y, Kwan E, Brown TJ, Gaisano H, Drucker DJ. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J Clin Invest 2012;122:388-402
29. Li B, Matter EK, Hoppert HT, Grayson BE, Seeley RJ, Sandoval DA. Identification of optimal reference genes for RT-qPCR in the rat hypothalamus and intestine for the study of obesity. Int J Obes (Lond) 2014;38:192-197
30. Kohan AB, Wang F, Li X, et al. Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride? Am J Physiol Gastrointest Liver Physiol 2013;304:G1128-G1135
31. Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014;509:183-188
32. Yin DP, Gao Q, Ma LL, et al. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Ann Surg 2011;254:73-82
33. Schneck A-S, Iannelli A, Patouraux S, et al. Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots. Surg Endosc 2014;28:592-602
34. Okada S, York DA, Bray GA, Erlanson-Albertsson C. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav 1991;49:1185-1189
35. Peters CT, Choi YH, Brubaker PL, Anderson GH. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats. J Nutr 2001;131:2164-2170
36. Stanley BG, Daniel DR, Chin AS, Leibowitz SF. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 1985;6:1205-1211
37. Shimbara T, Mondal MS, Kawagoe T, et al. Central administration of ghrelin preferentially enhances fat ingestion. Neurosci Lett 2004;369:75-79
38. Ritter S, Koegler FH, Wiater M. Effects of metabolic blockade on macronutrient selection. In Neural and Metabolic Control of Macronutrient Intake. Berthoud H-R, Seeley RJ, Eds. Boca Raton, FL, CRC Press, 1999, Chapter 13
39. Mansouri A, Koss MD, Brandt K, Geary N, Langhans W, Leonhardt M. Dissociation of mercaptoacetate's effects on feeding and fat metabolism by dietary medium- and long-chain triacylglycerols in rats. Nutrition 2008;24:360-365
40. Sclafani A, Ackroff K, Abumrad NA. CD36 gene deletion reduces fat preference and intake but not post-oral fat conditioning in mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R1823-R1832
41. Chambers AP, Smith EP, Begg DP, et al. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy. Am J Physiol Endocrinol Metab 2014;306:E424-E432
42. Shah S, Shah P, Todkar J, Gagner M, Sonar S, Solav S. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis 2010;6:152-157
43. Ali S, Lamont BJ, Charron MJ, Drucker DJ. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. J Clin Invest 2011;121:1917-1929
44. Cakir B, Kasimay O, Devseren E, Yegen BC. Leptin inhibits gastric emptying in rats: role of CCK receptors and vagal afferent fibers. Physiol Res 2007;56:315-322
45. Ohta T, Fidge NH, Nestel PJ. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. J Clin Invest 1985;76:1252-1260
46. Stefater MA, Perez-Tilve D, Chambers AP, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010;138:2426-2436.e1-3.
47. Langner CA, Birkenmeier EH, Ben-Zeev O, et al. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem 1989;264:7994-8003
48. Williams SC, Bruckheimer SM, Lusis AJ, Le Boeuf RC, Kinniburgh AJ. Mouse apolipoprotein A-IV gene: nucleotide sequence and induction by a high-lipid diet. Mol Cell Biol 1986;6:3807-3814
49. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 1985;75:384-390
50. Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 1995;15:963-971
51. Yamamoto T, Obika S, Nakatani M, et al. Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma. Eur J Pharmacol 2014;723:353-359
52. Dallongeville J, Delcroix A-G, Wagner A, et al. The APOA4 Thr347-. Ser347 polymorphism is not a major risk factor of obesity. Obes Res 2005;13:2132-2138
53. Miltiadous G, Hatzivassiliou M, Bashiardes E, Bairaktari E, Cariolou MA, Elisaf M. Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels. Clin Genet 2002;62:208-213
54. Wong WM, Hawe E, Li LK, et al. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res 2003;92:969-975
55. Guclu-Geyik F, Onat A, Coban N, et al. Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women. Mol Biol Rep 2012;39:10907-10914
56. Fisher RM, Burke H, Nicaud V, Ehnholm C, Humphries SE; EARS Group. Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res 1999;40:287-294
57. Lefevre M, Lovejoy JC, De Felice SM, et al. Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord 2000;24:945-953
58. Fiegenbaum M, Hutz MH. Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord 2003;27:484-490
59. Herron KL, Lofgren IE, Adiconis X, Ordovas JM, Fernandez ML. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis 2006;184:113-120
60. Talmud PJ, Hawe E, Martin S, et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002;11:3039-3046